Pacific Biosciences of California, Inc. Third Quarter 2021 Financial Results Call
MENLO PARK, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly…
Pharmaceuticals, Biotechnology and Life Sciences
MENLO PARK, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly…
PITTSBURGH, Oct. 19, 2021 (GLOBE NEWSWIRE) — Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for…
Sandusky, OH, Oct. 19, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) yesterday announced the launch of its…
1) Layout Ad Image for Oct 19 PR The layout of the Tauri-Gum™ Digital Ad Display This Campaign is Focused on…
Data from 5,518 Patients were Critical to Achieving the Broader IndicationCLEVELAND, Ohio, Oct. 19, 2021 (GLOBE NEWSWIRE) — SPR Therapeutics®…
Amendment to ongoing collaboration allows Wave to advance or partner CNS programs, including those using ADAR editing Takeda option to…
HOLLISTON, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third…
ROCKVILLE, Md., Oct. 18, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company…
— TORC 1/2 inhibitor sapanisertib and SYK inhibitor mivavotinib strengthen Company’s precision oncology pipeline — — Calithera will initiate Phase…
UNIONDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery,…